# Exagen Maintains 2026 Revenue Outlook at $72 Million to $75 Million

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/54314
Published: 2026-11-11T18:30:28.000Z
Updated: 2026-11-11T18:30:28.000Z
Section: Business

> Its myositis offering remains on track for an early 2027 launch.

Exagen Inc. maintained its full-year 2026 revenue outlook at $72 million to $75 million, while its myositis offering remains on track for an early 2027 launch.